chr19-3982933-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001961.4(EEF2):c.486C>T(p.Arg162Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000567 in 1,613,394 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00074 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00055 ( 7 hom. )
Consequence
EEF2
NM_001961.4 synonymous
NM_001961.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.05
Publications
6 publications found
Genes affected
EEF2 (HGNC:3214): (eukaryotic translation elongation factor 2) This gene encodes a member of the GTP-binding translation elongation factor family. This protein is an essential factor for protein synthesis. It promotes the GTP-dependent translocation of the nascent protein chain from the A-site to the P-site of the ribosome. This protein is completely inactivated by EF-2 kinase phosporylation. [provided by RefSeq, Jul 2008]
EEF2 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 26Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorderInheritance: AD Classification: MODERATE, LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-3982933-G-A is Benign according to our data. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-3982933-G-A is described in CliVar as Benign. Clinvar id is 585834.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.05 with no splicing effect.
BS2
High AC in GnomAd4 at 112 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000742 AC: 113AN: 152214Hom.: 2 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
113
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00119 AC: 297AN: 249652 AF XY: 0.00131 show subpopulations
GnomAD2 exomes
AF:
AC:
297
AN:
249652
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000550 AC: 803AN: 1461062Hom.: 7 Cov.: 32 AF XY: 0.000563 AC XY: 409AN XY: 726866 show subpopulations
GnomAD4 exome
AF:
AC:
803
AN:
1461062
Hom.:
Cov.:
32
AF XY:
AC XY:
409
AN XY:
726866
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33476
American (AMR)
AF:
AC:
4
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26134
East Asian (EAS)
AF:
AC:
605
AN:
39686
South Asian (SAS)
AF:
AC:
38
AN:
86214
European-Finnish (FIN)
AF:
AC:
0
AN:
52770
Middle Eastern (MID)
AF:
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
90
AN:
1111934
Other (OTH)
AF:
AC:
62
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000735 AC: 112AN: 152332Hom.: 2 Cov.: 33 AF XY: 0.000832 AC XY: 62AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
112
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
62
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
4
AN:
41580
American (AMR)
AF:
AC:
2
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
92
AN:
5172
South Asian (SAS)
AF:
AC:
5
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7
AN:
68030
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
38
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 22, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.